{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:35:53Z","timestamp":1793381753790,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) have been increasingly available in Europe. Due to the high burden of HIV in key populations, these could benefit from their use. In 2016, in Portugal, an open, non-interval, prospective cohort study was established in a network of 26 community-based voluntary HIV\/STI counseling and testing centers. Data collected included questions on PEP and PrEP knowledge and use. We aimed to estimate the proportion of PEP and PrEP knowledge and its use among key populations, visiting the centers between 2016 and 2019.<\/jats:p><jats:p><jats:bold>Method and results:<\/jats:bold> Individuals who self-identify as being among at least one key population for HIV, men who have sex with men (MSM), people who inject drugs (PWID), sex workers (SW), migrants, and male-to-female transgender individuals (MTF), responded to questions on PEP and PrEP knowledge and use while waiting for their test results between 2016 and 2019 (<jats:italic>n<\/jats:italic> = 12,893 for PEP; <jats:italic>n<\/jats:italic> = 10,973 for PrEP). Reported knowledge was low in all key populations for both tools: 15.7% of respondents reported knowing about PEP and 10.9% about PrEP over the course of 4 years. PEP was used by 1.8% and PrEP by 0.4% of the respondents, MSM being 88.9% of PrEP users, and 52.8% of PEP users. Multivariate logistic regression showed multiple factors associated with knowing the tools, including age, education, country of birth, gender, year of test, having a reactive HIV test in the same visit, reporting an STI or condomless sex in the last 12 months, and identifying with being MSM or SW.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Knowledge and use of PEP and PrEP remain low among key populations in Portugal. The need remains to increase knowledge and use among those at risk for HIV infection.<\/jats:p>","DOI":"10.3389\/fpubh.2021.673959","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T06:56:09Z","timestamp":1627023369000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Knowledge and Use of PEP and PrEP Among Key Populations Tested in Community Centers in Portugal"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniel","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Meireles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"B1","unstructured":"WHO Regional Office for Europe. HIV\/AIDS Surveillance in Europe 2020 - 2019 Data2020"},{"key":"B2","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade\/Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge. Infe\u00e7\u00e3o VIH e SIDA em Portugal2020"},{"key":"B3","unstructured":"Infe\u00e7\u00e3o VIH e SIDA em Portugal - 20192019"},{"key":"B4","unstructured":"Preven\u00e7\u00e3o da infe\u00e7\u00e3o por VIH | SNS242021"},{"key":"B5","volume-title":"Post-Exposure Prophylaxis to Prevent HIV Infection: Joint WHO\/ILO Guidelines on Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection","year":"2007"},{"key":"B6","unstructured":"Despacho 6716\/2012, 2012-05-172012"},{"key":"B7","unstructured":"2018"},{"key":"B8","unstructured":"JorgeM\n          Consulta de Profilaxia P\u00f3s-Exposi\u00e7\u00e3o a VIH - Casu\u00edstica da consulta do servi\u00e7o de doen\u00e7as infecciosas do Hospital de Santa Maria no per\u00edodo 2009-20142016"},{"key":"B9","volume-title":"Profilaxia com Antiretrovirais nos Acidentes de Exposi\u00e7\u00e3o a Fluidos Org\u00e2nicos no Servi\u00e7o de Urg\u00eancia do Hospital Prof. Dr. Fernando Fonseca EPE. Introdu\u00e7\u00e3o","author":"Elias","year":"2009"},{"key":"B10","unstructured":"BorgesA\n            GuerreiroC\n            ParedesP\n            NabaisH\n            MansinhoK\n          Normas de Actua\u00e7\u00e3o ap\u00f3s Exposi\u00e7\u00e3o Acidental a Produtos Biol\u00f3gicos Potencialmente Infectantes. Arquivo da Maternidade Dr. Alfredo da Costa2000"},{"key":"B11","unstructured":"AfonsoD\n          Exposi\u00e7\u00e3o ocupacional a material biol\u00f3gico em medicina dent\u00e1ria2015"},{"key":"B12","unstructured":"Anexo I - Resumo das Caracter\u00edsticas do Medicamento Truvada, INN-Emtricitabine\/TenofovirDisoproxil2010"},{"key":"B13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/ciz486","article-title":"Changes in bone mass after discontinuation of preexposure prophylaxis with tenofovir disoproxil fumarate\/emtricitabine in young men who have sex with men: extension phase results of adolescent trials network protocols 110 and 113","volume":"70","author":"Havens","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B14","unstructured":"Truvada for PrEP Fact Sheet : Ensuring Safe and Proper Use2012"},{"key":"B15","unstructured":"Norma n\u00b0 025\/2017 de 28\/11\/2017 atualizada a 16\/05\/2018\n            Minist\u00e9rioda Sa\u00fade; Dire\u00e7\u00e3o Geral da Sa\u00fade\n          2017"},{"key":"B16","unstructured":"Circular, Normativa Conjunta n,.\u00b0 01\/2018 do INFARMED\/ACSS\/DGS\/SPMS de 13 de mar\u00e7o de 2018, sobre o Programa de Acesso Precoce para Profilaxia de Pr\u00e9-exposi\u00e7\u00e3o da infe\u00e7\u00e3o por VIH-1 no Adulto"},{"key":"B17","unstructured":"Circular, Normativa Conjunta n,.\u00b0 02\/2018 do INFARMED\/ACSS\/DGS\/SPMS de 13 de mar\u00e7o de 2018, sobre o Programa de Acesso Precoce para Profilaxia de Pr\u00e9-exposi\u00e7\u00e3o da infe\u00e7\u00e3o por VIH-1 no Adulto"},{"key":"B18","unstructured":"INFARMED - Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I,.P. Relat\u00f3rio P\u00fablico de Avalia\u00e7\u00e3o Pr\u00e9via do Medicamento Truvada (PrEP) em Meio Hospitalar2018"},{"key":"B19","unstructured":""},{"key":"B20","first-page":"S383","article-title":"Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State: New York City and Long Island, NY, 2011-2013","volume-title":"J Acquir Immune Defic Syndr","author":"Walters","year":"2017"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/j.lanwpc.2020.100086","article-title":"HIV non-occupational post-exposure prophylaxis (nPEP) awareness and promotion among five key populations in China: A cross-sectional study","volume":"7","author":"Li","year":"2021","journal-title":"Lancet Reg Heal"},{"key":"B22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/apc.2019.0313","article-title":"HIV Non-occupational Post-exposure prophylaxis among men who have sex with men: a systematic review and meta-analysis of global data","volume":"34","author":"Wang","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0157339","DOI":"10.1371\/journal.pone.0157339","article-title":"PEP and TasP Awareness among Italian MSM, PLWHA, and high-risk heterosexuals and demographic, behavioral, and social correlates","volume":"11","author":"Prati","year":"2016","journal-title":"PLoS ONE"},{"key":"B24","volume-title":"EMIS-2017 \u2013 The European Men-Who-Have-Sex-With-Men Internet Survey. Key findings From 50 Countries. Stockholm: European Centre for Disease Prevention and Control","year":"2019"},{"key":"B25","unstructured":"Dublin Declaration evidence brief: PrEP2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1900598","DOI":"10.2807\/1560-7917.ES.2019.24.41.1900598","article-title":"Estimating the \u2018PrEP Gap': how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019","volume":"24","author":"Hayes","year":"2019","journal-title":"Eurosurveillance"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s10461-020-03127-2","article-title":"Provision of pre-exposure prophylaxis at the Portuguese national health service and uptake in the Lisbon cohort of men who have sex with men","volume":"25","author":"Meireles","year":"2021","journal-title":"AIDS Behav."},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/apc.2018.0182","article-title":"Awareness and interest in HIV pre-exposure prophylaxis among street-based female sex workers: results from a US context","volume":"33","author":"Tomko","year":"2019","journal-title":"AIDS Patient Care STDS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","article-title":"Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature","volume":"21","author":"Koechlin","year":"2017","journal-title":"AIDS Behav."},{"key":"B30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(14)60974-0","article-title":"Combination HIV prevention for female sex workers: what is the evidence?","volume":"385","author":"Bekker","year":"2015","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s10461-012-0317-8","article-title":"High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya","volume":"17","author":"Van","year":"2013","journal-title":"AIDS Behav"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e25081","DOI":"10.1002\/jia2.25081","article-title":"Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa","volume":"21","author":"Eakle","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"B33","article-title":"Willingness to take daily oral HIV pre-exposure prophylaxis (PrEP) among young women and female sex workers in Kenya","volume-title":"The 22nd International AIDS Conference (AIDS 2018)","author":"Karagu","year":"2018"},{"key":"B34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/QAI.0000000000002134","article-title":"PrEP use among female sex workers: no evidence for risk compensation","volume":"82","author":"Gigu\u00e8re","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"18899","DOI":"10.7448\/IAS.17.1.18899","article-title":"HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research","volume":"17","author":"Escudero","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","article-title":"The Pre-exposure Prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review","volume":"25","author":"Mistler","year":"2021","journal-title":"AIDS Behav."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e25391","DOI":"10.1002\/jia2.25391","article-title":"High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States","volume":"22","author":"Reisner","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1007\/s10461-018-2175-5","article-title":"Post-exposure prophylaxis awareness, knowledge, access and use among three populations in New York City, 2016-17","volume":"22","author":"Koblin","year":"2018","journal-title":"AIDS Behav"},{"key":"B39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","year":"2016","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0246037","DOI":"10.1371\/journal.pone.0246037","article-title":"Yes, I'm interested in taking PrEP!\u201d: PrEP interest among women respondents to the European community-based survey \u201cFlash! PrEP in Europe\u201d","volume":"16","author":"Delabre","year":"2021","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"21091","DOI":"10.2807\/1560-7917.es2015.20.14.21091","article-title":"Incident risk factors as predictors of HIV seroconversion in the Lisbon cohort of men who have sex with men: First results, 2011-2014","volume":"20","author":"Meireles","year":"2015","journal-title":"Euro Surveill"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.673959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T06:57:02Z","timestamp":1627023422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.673959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":41,"alternative-id":["10.3389\/fpubh.2021.673959"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2021.673959","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"article-number":"673959"}}